Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
Stopped PI choice; poor accrual
Conditions
- ATM Gene Mutation
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- BRIP1 Gene Mutation
- CDK12 Gene Mutation
- CHEK1 Gene Mutation
- CHEK2 Gene Mutation
- DNA Damage Response Gene Mutation
- DNA Repair Gene Mutation
- FANCA Gene Mutation
- FANCD2 Gene Mutation
- FANCL Gene Mutation
- GEN1 Gene Mutation
- NBN Gene Mutation
- Prostate Carcinoma
- RAD51 Gene Mutation
- RAD51C Gene Mutation
Interventions
- DRUG: Niraparib
- DRUG: Niraparib Tosylate Monohydrate
- PROCEDURE: Radical Prostatectomy
Sponsor
University of California, Davis
Collaborators
- [object Object]
- [object Object]